Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
30 studies found for:    " September 19, 2007":" October 19, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed Reducing Sex-Related HIV Risk Behaviors in Patients Receiving Treatment for Opioid Dependence
Conditions: Opiate Dependence;   HIV Infections
Interventions: Behavioral: Enhanced Sexual Risk Management;   Behavioral: Standard Sexual Risk Management
22 Completed Effect of Soluble Fiber on Hypertriglyceridemia and Immune Profile in HIV-positive Individuals.
Conditions: Hypertriglyceridemia;   HIV Infections
Intervention: Dietary Supplement: soluble fiber® (partially hydrolyzed guar gum)
23 Terminated Randomized Clinical Trial to Assess the Efficacy and Safety of Concomitant Use of Rifampicin and Efavirenz 600 X 800mg
Conditions: Tuberculosis;   HIV Infections
Intervention: Drug: efavirenz
24 Completed
Has Results
TMC278-TiDP6-C209: A Clinical Trial in Treatment Naive HIV-1 Patients Comparing TMC278 to Efavirenz in Combination With Tenofovir + Emtricitabine.
Conditions: HIV Infections;   HIV-1;   Human Immunodeficiency Virus Type 1
Interventions: Drug: TMC278;   Drug: Efavirenz
25 Completed Effects of Anti-HIV Drugs on the Hepatitis C Virus (HCV) in Adults Infected With Both HCV and HIV
Conditions: Hepatitis C;   HIV Infections
Interventions: Drug: Efavirenz;   Drug: Emtricitabine/Tenofovir disoproxil fumarate
26 Unknown  Diagnosis of Tuberculosis Infection in HIV Co-infected Children
Conditions: Latent Tuberculosis Infection;   Tuberculosis;   HIV Infections
Intervention:
27 Unknown  The Effect of Probiotics on the Immune Status, Diarrhea and Bacterial Vaginosis Cure Rate Among HIV Patients
Conditions: HIV Infections;   Diarrhea;   Bacterial Vaginosis
Interventions: Dietary Supplement: Lactobacillus rhamnosus GR-1 + Lactobacillus reuteri RC-14;   Dietary Supplement: Placebo;   Drug: Metronidazole
28 Completed
Has Results
A Study to Evaluate the Pharmacokinetic Profile (How the Body Absorbs, Distributes, Metabolizes and Eliminates a Drug) of TMC125 Plus Tenofovir/Emtricitabine Once Daily With or Without Darunavir/r Once Daily in Antiretroviral (ARV) Naive HIV-1 Patients (Patients Have Never Received ARV Treatment).
Condition: HIV-1 Infection
Intervention: Drug: TMC125; darunavir; ritonavir
29 Terminated GSK706769 A First Time in Human Study For Males and Females
Condition: Healthy Subjects
Intervention: Drug: GSK706769
30 Unknown  Drug Counseling and Abstinent-Contingent Take-Home Buprenorphine in Malaysia
Condition: Opiate Dependence
Interventions: Behavioral: behavioral drug and HIV risk reduction counseling (BDRC);   Behavioral: abstinence-contingent take-home buprenorphine (ACB);   Behavioral: Physician Management (PM)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-30) Next Page   
Study has passed its completion date and status has not been verified in more than two years.